Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00371670 | Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee | PHASE2 | COMPLETED | 223 | — | — | Dec 1, 2004 | - | Mar 28, 2017 | 2 | United States, Germany |
| Name | Type | Description |
|---|---|---|
| balicatib (AAE581) | DRUG | - |
Inclusion Criteria: * At least one knee with osteoarthritis with Kellgren-Lawrence grade 3 * Significant osteoarthritis pain in the knee * Presence of at least one of the risk factors: obesity (BMI \> 28), osteoarthritis at other sites, knee effusion, family history of total joint replacement Excl...